{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:54:58Z","timestamp":1792007698671,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T00:00:00Z","timestamp":1389312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00125-013-3149-9","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T02:32:20Z","timestamp":1389234740000},"page":"878-890","source":"Crossref","is-referenced-by-count":113,"title":["The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial"],"prefix":"10.1007","volume":"57","author":[{"given":"Yumie","family":"Takeshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Misu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuguhito","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sunagozaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"3149_CR1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/dc09-0148","volume":"33","author":"E Hamaguchi","year":"2010","unstructured":"Hamaguchi E, Takamura T, Sakurai M et al (2010) Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis. Diabetes Care 33:284\u2013286","journal-title":"Diabetes Care"},{"key":"3149_CR2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00535-006-1948-","volume":"42","author":"M Sakurai","year":"2007","unstructured":"Sakurai M, Takamura T, Ota T et al (2007) Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol 42:312\u2013317","journal-title":"J Gastroenterol"},{"key":"3149_CR3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.21874","volume":"46","author":"N Matsuzawa","year":"2007","unstructured":"Matsuzawa N, Takamura T, Kurita S et al (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46:1392\u20131403","journal-title":"Hepatology"},{"key":"3149_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","volume":"4","author":"M Mar\u00ed","year":"2006","unstructured":"Mar\u00ed M, Caballero F, Colell A et al (2006) Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4:185\u2013198","journal-title":"Cell Metab"},{"key":"3149_CR5","doi-asserted-by":"crossref","first-page":"14809","DOI":"10.1074\/jbc.M901488200","volume":"29","author":"S Nakamura","year":"2009","unstructured":"Nakamura S, Takamura T, Matsuzawa-Nagata N et al (2009) Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 29:14809\u201314818","journal-title":"J Biol Chem"},{"key":"3149_CR6","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","volume":"102","author":"M Garcia-Calvo","year":"2005","unstructured":"Garcia-Calvo M, Lisnock J, Bull HG et al (2005) The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc Natl Acad Sci U S A 102:8132\u20138137","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3149_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.metabol.2010.06.008","volume":"60","author":"T Muraoka","year":"2011","unstructured":"Muraoka T, Aoki K, Iwasaki T et al (2011) Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. Metabolism 60:617\u2013628","journal-title":"Metabolism"},{"key":"3149_CR8","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1016\/j.febslet.2007.11.023","volume":"581","author":"M Deushi","year":"2007","unstructured":"Deushi M, Nomura M, Kawakami A et al (2007) Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett 581:5664\u20135670","journal-title":"FEBS Lett"},{"key":"3149_CR9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1872-034X.2010.00644.x","volume":"40","author":"M Yoneda","year":"2010","unstructured":"Yoneda M, Fujita K, Nozaki Y et al (2010) Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study. Hepatol Res 40:613\u2013621","journal-title":"Hepatol Res"},{"key":"3149_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00535-010-0291-8","volume":"46","author":"H Park","year":"2011","unstructured":"Park H, Shima T, Yamaguchi K et al (2011) Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol 46:101\u2013107","journal-title":"J Gastroenterol"},{"key":"3149_CR11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.20012","volume":"39","author":"K Promrat","year":"2004","unstructured":"Promrat K, Lutchman G, Uwaifo GI et al (2004) A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39:188\u2013196","journal-title":"Hepatology"},{"key":"3149_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"3149_CR13","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K et al (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402\u20132410","journal-title":"J Clin Endocrinol Metab"},{"key":"3149_CR14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/hep.25739","volume":"56","author":"G Musso","year":"2012","unstructured":"Musso G, Cassader M, de Michieli F, Rosina F, Orlandi F, Gambino R (2012) Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. Hepatology 56:933\u2013942","journal-title":"Hepatology"},{"key":"3149_CR15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/db12-0858","volume":"62","author":"G Musso","year":"2013","unstructured":"Musso G, Cassader M, Bo S, de Michieli F, Gambino R (2013) Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism. Diabetes 62:1109\u20131120","journal-title":"Diabetes"},{"key":"3149_CR16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","volume":"133","author":"A Gastaldelli","year":"2007","unstructured":"Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA (2007) Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133:496\u2013506","journal-title":"Gastroenterology"},{"key":"3149_CR17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jnutbio.2009.06.007","volume":"21","author":"G Musso","year":"2010","unstructured":"Musso G, Gambino R, Cassader M (2010) Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. J Nutr Biochem 21:834\u2013840","journal-title":"J Nutr Biochem"},{"key":"3149_CR18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc06-1331","volume":"30","author":"MA Abdul-Ghani","year":"2007","unstructured":"Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M (2007) What is the best predictor of future type 2 diabetes? Diabetes Care 30:1544\u20131548","journal-title":"Diabetes Care"},{"key":"3149_CR19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"},{"key":"3149_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc06-1519","volume":"30","author":"MA Abdul-Ghani","year":"2007","unstructured":"Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89\u201394","journal-title":"Diabetes Care"},{"key":"3149_CR21","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214\u2013E223","journal-title":"Am J Physiol"},{"key":"3149_CR22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2337\/diacare.22.6.1004b","volume":"22","author":"Y Nagai","year":"1999","unstructured":"Nagai Y, Takamura T, Nohara E et al (1999) Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men. Diabetes Care 22:1004","journal-title":"Diabetes Care"},{"key":"3149_CR23","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467\u20132474","journal-title":"Am J Gastroenterol"},{"key":"3149_CR24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, van Natta M et al (2005) Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"3149_CR25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1073\/pnas.98.4.1477","volume":"13","author":"RA DeBose-Boyd","year":"2001","unstructured":"DeBose-Boyd RA, Ou J, Goldstein JL, Brown MS (2001) Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proc Natl Acad Sci U S A 13:1477\u20131482","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3149_CR26","doi-asserted-by":"crossref","first-page":"302847","DOI":"10.1155\/2012\/302847","volume":"2012","author":"O Bari de","year":"2012","unstructured":"de Bari O, Neuschwander-Tetri BA, Liu M et al (2012) Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic fatty liver disease. J Lipids 2012:302847","journal-title":"J Lipids"},{"key":"3149_CR27","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1194\/jlr.M006353","volume":"51","author":"L Jia","year":"2010","unstructured":"Jia L, Ma Y, Rong S et al (2010) Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis. J Lipid Res 51:3135\u20133144","journal-title":"J Lipid Res"},{"key":"3149_CR28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","volume":"52","author":"G Musso","year":"2013","unstructured":"Musso G, Gambino R, Cassader M (2013) Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid Res 52:175\u2013191","journal-title":"Prog Lipid Res"},{"key":"3149_CR29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2011.09.049","volume":"142","author":"T Teratani","year":"2012","unstructured":"Teratani T, Tomita K, Suzuki T et al (2012) A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. Gastroenterology 142:152\u2013164","journal-title":"Gastroenterology"},{"key":"3149_CR30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","volume":"303","author":"SW Altmann","year":"2004","unstructured":"Altmann SW, Davis HR Jr, Zhu LJ et al (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201\u20131204","journal-title":"Science"},{"key":"3149_CR31","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI30060","volume":"117","author":"RE Temel","year":"2007","unstructured":"Temel RE, Brown JM, Ma Y et al (2007) Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest 117:1968\u20131978","journal-title":"J Clin Invest"},{"key":"3149_CR32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.21752","volume":"46","author":"S Joshi-Barve","year":"2007","unstructured":"Joshi-Barve S, Barve SS, Amancherla K et al (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46:823\u2013830","journal-title":"Hepatology"},{"key":"3149_CR33","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1210\/en.2006-1710","volume":"148","author":"MJ Pagliassotti","year":"2007","unstructured":"Pagliassotti MJ, Wei Y, Wang D (2007) Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity. Endocrinology 148:3338\u20133345","journal-title":"Endocrinology"},{"key":"3149_CR34","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi H, Bronk SF, Werneburg NW, Gores GJ (2006) Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 281:12093\u201312101","journal-title":"J Biol Chem"},{"key":"3149_CR35","doi-asserted-by":"crossref","first-page":"33652","DOI":"10.1074\/jbc.M110.152090","volume":"285","author":"I Gerin","year":"2010","unstructured":"Gerin I, Clerbaux LA, Haumont O et al (2010) Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem 285:33652\u201333661","journal-title":"J Biol Chem"},{"key":"3149_CR36","doi-asserted-by":"crossref","first-page":"37991","DOI":"10.1074\/jbc.M205087200","volume":"277","author":"JF Louet","year":"2002","unstructured":"Louet JF, Hayhurst G, Gonzalez FJ et al (2002) The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB). J Biol Chem 277:37991\u201338000","journal-title":"J Biol Chem"},{"key":"3149_CR37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/me.2007-0531","volume":"23","author":"X Xuefen","year":"2009","unstructured":"Xuefen X, Hailing L, Huaixin D et al (2009) Down-regulation of hepatic HNF4_ gene expression during hyperinsulinemia via SREBPs. Mol Endocrinol 23:434\u2013443","journal-title":"Mol Endocrinol"},{"key":"3149_CR38","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1073\/pnas.1008499107","volume":"107","author":"T Horie","year":"2010","unstructured":"Horie T, Ono K, Horiguchi M et al (2010) MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci U S A 107:17321\u201317326","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3149_CR39","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1161\/ATVBAHA.111.226688","volume":"31","author":"C Fern\u00e1ndez-Hernando","year":"2011","unstructured":"Fern\u00e1ndez-Hernando C, Moore KJ (2011) MicroRNA modulation of cholesterol homeostasis. Arterioscler Thromb Vasc Biol 31:2378\u20132382","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3149_CR40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","volume":"55","author":"G Musso","year":"2012","unstructured":"Musso G, Cassader M, Rosina F, Orlandi F, Gambino R (2012) Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55:885\u2013904","journal-title":"Diabetologia"},{"key":"3149_CR41","doi-asserted-by":"crossref","first-page":"15628","DOI":"10.1074\/jbc.M800391200","volume":"6","author":"MK Bennett","year":"2008","unstructured":"Bennett MK, Seo YK, Datta S, Shin DJ, Osborne TF (2008) Selective binding of sterol regulatory element-binding protein isoforms and co-regulatory proteins to promoters for lipid metabolic genes in liver. J Biol Chem 6:15628\u201315637","journal-title":"J Biol Chem"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-3149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-013-3149-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-3149-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:49:52Z","timestamp":1558597792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-013-3149-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["3149"],"URL":"https:\/\/doi.org\/10.1007\/s00125-013-3149-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,10]]}}}